Since 2015 Cann10 has become a point of knowledge and innovation in the Medical Cannabis ecosystem, pioneering Pharma-Grade cannabis brand, establishing its position as a player in this global industry, demonstrating significant expertise and network across the value chain. Owner medical cannabis products registered and distributed on pharmacies, education pioneers worldwide, Founder of CannX International medical cannabis conferences, CME Accreditation approved conference (UEMS).

Intelligent investing

In a business that is still considered by many to be extremely risky, there are many excellent opportunities to earn significant returns on investment.  It all depends on who you invest with and what you are investing in. Seeach Farm, a Cann10 partner, has been successfully operating  in medical cannabis business for years.  Cann10 has its own license, from the Israel Ministry of Health,  to manufacture  medical cannabis products.  We also work around the world, so our outlook is global.

Cann10 Holds a unique ability to support all professional and business know how in the Medical Cannabis Value chain. We have a hands on experience on Growing methods, Botanical R&D, Medical Devices and Pharma technologies, Clinical Trials and regulation.

Global Trade

Medical Cannabis is breaking down borders and becoming an important trade commodity.  Cann10 is uniquely positioned to help fill supply gaps with top quality GMP-approved product from around the world.  Thanks to our experience in the pharma world, we are aware of global requirements for shipping, licensing, trading and regulatory issues.  We can save time, money and hassle and ensure you open new markets or get the high product you require.

Cann10 is currently developing new farms and production facilities in Europe, North America, Asia and Australia to supply everything from CBD and THC or CBD only, flowers to oils, tables to vaps. We are also developing our own branded line of “Cannareet” – products that will carry the approval GMP and all necessary local certification.

If you are a distributor, produce medical cannabis or require product, please contact us so we can meet your most demanding criteria.


Education Services

Although the world of medical cannabis is rapidly expandin, there is a lack of professional education available for those involved in growing, producing, prescribing and monitoring patients.

Joint University Programs

Cann10 has and continuesto establish connections with leading universities to provide high-level courses for a wide range of students including investors, lawyers, accountants, entrepreneurs, physicians, pharmacists, nurses, farmers,  and producers. Currently, we offer certificate courses with Israel’s famed Technion and Australia’s Deakin University .This 32 hour course covers everything from plant physiology, growing, farming, medical knowledge, science, technology, marketing, branding, regulations, patient care and more.

Cann10 is interested in working with other leading universities. We provide the course content and the partner university provides lecturers and localizes content. For more information please contact us

Professional Education  CME

Cann10 offers specialized and accredited courses for Physicians, Pharmacists, Nurses and Care Givers.  Attendees will earn CME credits and gain valuable insight into the advances, dosing and treatment of patients.  For more information, please contact us.

E-learning

Cann10 is currently developing a number of e- learning courses. These will nclude a variety of  modules that can be used on a mobile phone or laptop .


Production

Cann10 is interested in taking an equity position in production facilities worldwide.  We bring extensive experience, a well developed building, outfitting and preparation program together with  the expertise to cut the time needed to turn an empty space into a revenue generating facility.  We do not provide this as a service, but will provide the necessary know-how, plants, technologies and techniques to farms in which we are partners.  We are currently involved in new projects in Canada, Portugal, Australia and other locations.